Rachna Murthy has over a decade of NHS consultant oculoplastic surgical and aesthetic medicine experience and is a leading voice in ocular and aesthetic medicine. She is widely published in aesthetics and surgery and has pioneered innovative surgical approaches to periocular skin cancer resulting in reduced patient attendance and cancer recurrence with improved cosmetic outcomes. She led the quaternary thyroid eye disease service at Cambridge University Hospital and oculoplastic service in East Suffolk for over a decade before entering full time private practice in London, Harley Street, Lanserhof at the Arts Club, Mayfair and Cambridge. She enjoys faculty status at numerous international meetings and has been appointed as faculty to the Allergan Medical Institute and the board of IMCAS Alert, as an expert supporting aesthetic practitioners with complications. Rachna has pioneered innovative surgical approaches to periocular skin cancer resulting in reduced patient attendance and cancer recurrence with improved cosmetic outcomes. She is a patient advocate and sits on the board of the Royal Society of Medicine's Ophthalmology section. Her publications have won international prizes and are widely quoted. She is an invited author for the Tear Film & Ocular Surface Society, on the editorial board for PMFA Journal, has been awarded consultant surgeon of the year 2022 by Aesthetics Media and is listed in the Spears 500, and Tatler as a top cosmetic and oculoplastic surgeon. Dr Murthy is amongst a handful of UK surgeons that has been invited to be a full member of the British, European and American Societies of Ophthalmic Plastic, Aesthetic and Reconstructive Surgery.  She is a co-inventor of Purifeyes, a periocular antimicrobial solution for dry eyes.